CClinicalTrials.gg
Not yet recruitingNCT06297057MEEGOPTIUpdated Mar 6, 2024

Acquisition and Analysis Protocol Optimization of Neurophysiological Data Neurorehabilitation Settings

An interventional study of Neurophysiological Recordings in Healthy, sponsored by IRCCS San Camillo, Venezia, Italy. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by IRCCS San Camillo, Venezia, Italy · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The study aims to optimize and validate protocols for acquiring neurophysiological data, specifically resting state functional connectivity, using advanced research techniques (hdEEG and MEG) and a user-friendly device (MUSE). Previous studies have extensively explored functional connectivity repeatability in resting conditions using functional MRI, yet few have focused on hdEEG and MEG data. Additionally, the impact of subjects' eye conditions (open or closed) during resting state recordings on network identification remains debated.

The investigation involves assessing the effect of eye conditions on brain network identification and determining the most stable and repeatable measures of functional connectivity over time. This analysis is crucial for discerning whether observed changes in patients' functional connections are intrinsic to the methodology or indicative of genuine physiological alterations.

The study aims to optimize protocols for rehabilitation by evaluating changes in functional connectivity metrics during and between experimental sessions. Furthermore, it seeks to identify the conditions (eyes closed or open) that yield more reliable and repeatable functional measurements.

Following the optimization of advanced techniques, the study explores the feasibility of utilizing the MUSE EEG system in clinical settings. MUSE, known for its portability and user-friendliness, has demonstrated quality in experimental psychology and clinical research. The objective is to establish relevant functional correspondences between measurements obtained through research techniques (hdEEG and MEG) and those acquired with MUSE.

The primary goal is to establish a protocol highlighting subjects' responses to acoustic stimuli or a reproducible pattern of resting state activity. The secondary objectives include investigating temporal and spatial characteristics of neurophysiological signals in healthy subjects over time and defining prognostic biomarkers for monitoring patients undergoing rehabilitation. This comprehensive approach aims to enhance the understanding of resting state functional connectivity and its applications in clinical settings.

Therefore, to meet these goals, the present study will consist of multiple recordings of brain activity: by high-density electroencephalography (hdEEG), magnetoencephalography (MEG), and low-density EEG with a MUSE handheld device, during five experimental blocks on healthy subjects.

Read the detailed description

Participants who will be identified as suitable for hdEEG, MEG, and MUSE recording will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE.

The sessions will take place in three consecutive weeks, once a week, taking care that these recordings are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant.

Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block.

The four blocks in the resting condition will always be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between participants and between different sessions for the same participant.

02

Conditions studied

  • Healthy

Keywords

  • connectivity
  • MEEG
  • resting state
  • Mismatch Negativity (MMN)
  • Auditory Steady State Response (ASSR)
03

In context

Lead sponsor

IRCCS San Camillo, Venezia, Italy is the lead sponsor of 48 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age between 18 and 65
  • ability to sign an informed consent form

Exclusion criteria

Exclusion Criteria:

  • has suffered/is suffering from epileptic seizures.
  • has had severe neurological or psychiatric disorders
  • has eyesight problems that prevent him/her from reading, which she cannot correct with contact lenses (she will not be able to wear glasses during registration)
  • habitually abused drugs or abused alcoholic substances
  • has abused substances such as alcohol or drugs in the last three days
  • is a wearer of hearing aids
  • has metal and/or skull clips or other metal in any part of the head except the mouth
  • has non-removable tattoos
  • has piercings, earrings or other metal accessories that cannot be removed.
  • is or could be pregnant (pregnancy in the first trimester)
  • is a carrier of sickle cell anaemia
  • is a cardiac pacemaker wearer or has an artificial heart valve
  • has mechanical devices that he/she uses to administer medication
  • has a surgical clip (vascular clips and metallic arterial prostheses made of ferromagnetic material)
  • has a cochlear implant, a neurostimulator or a programmable hydrocephalic electrical conductor (shunt)
  • has had brain surgery
  • has implants or metal fragments in the body
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Neurophysiological Recordings

    Participants suitable for hdEEG, MEG, and MUSE recordings will first undergo a neuronavigation session, and then three identical neurophysiological data acquisition sessions, one for hdEEG, one for MEG, and one for MUSE. The sessions will take place in three consecutive weeks, once a week, taking care that they are made at the same time of day for each participant. Finally, a structural magnetic resonance imaging (MRI) recording will be obtained for each participant. Each neurophysiological data acquisition session will consist of 5 blocks: 4 eyes-open and eyes-closed resting-state blocks, and one passive auditory stimulation block. The four blocks in the resting condition will be performed first, to avoid interference due to the passive acoustic task. The order of blocks 1 and 2, and consequently also blocks 3 and 4, representing the open-eye and closed-eye conditions will be counterbalanced between subjects and between different sessions for the same subject.

    Other: Neurophysiological Recordings

Interventions

  • OtherNeurophysiological Recordings

    Eyes-open resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes open and staring at a white cross in the center of a light grey screen to limit their eye movements. Eyes-closed resting-state blocks: these blocks will last 5 minutes each. Subjects will be asked to relax and not think about anything specific, keeping their eyes closed. ASSR: this block will last approximately 6 minutes. Stimuli will consist of a train of sounds presented repeatedly at high frequency. MMN: this block will last approximately 3 minutes. Stimuli will consist of a train of equal sounds presented alternating with a 'deviant' (rarer frequency) sound.

06

What researchers measure

Primary outcomes

  1. Neurophysiological data acquisition protocol - resting state

    Resting state measure from MEEG data: Power spectrum density values (delta, theta, alpha, beta, gamma frequency)

    Time frame: T1: first week, T2: second week, T3: third week

  2. Neurophysiological data acquisition protocol - resting state

    Resting state measure from MEEG data: Connectivity values at source level (delta, theta, alpha, beta, gamma frequency)

    Time frame: T1: first week, T2: second week, T3: third week

  3. Neurophysiological data acquisition protocol - auditory stimulation

    ASSR response (as measured from auditory stimulation)

    Time frame: T1: first week, T2: second week, T3: third week

07

Study locations

1 site
  • San Camillo IRCCS s.r.l.
    Venice-Lido, Venice 30126, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06297057
Lead sponsor
IRCCS San Camillo, Venezia, Italy
Collaborators
University Ghent, University of Padova
Responsible party
Sponsor
First posted
Mar 6, 2024
Start date
Mar 2024 (estimated)
Primary completion
Mar 2025 (estimated)
Completion
Mar 2026 (estimated)
Last update
Mar 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion